New DES stents to be introduced to the Indian market soon
Time to move away from metal stents to this new generation of core wire stents which are more flexible with thinner struts and, in addition, offer no increased risk of stent thrombosis later
Hungary possesses the new solution for millions suffering from coronary artery diseases in India. Budapest-based Gottsegen Gyorgy Hungarian Institute of Cardiology has treated around 80 patients till now, with the new resolute onyx drug-eluting stent using the core wire technology. This new stent has thinner struts to help improve deliverability without compromising radial and longitudinal strength of the stent.
In addition, this new stent has no increased risk for stent thrombosis with interruption or discontinuation of dual antiplatelet therapy (DAPT) after a month. The Cobalt alloy shell of this new stent discovery is more flexible and, maintains the mechanical performance and structural strength of the stent material.
According to PTI,
"From a plain vanilla bare metal stent to the new generation Resolute Onyx drug eluting stents, it is a kind of revolution in stent technology," Chief of Adult Cardiology of Budapest-based Gottsegen Gyorgy Hungarian Institute of Cardiology Peter Andreka said.
Core Wire Technology is the next new DES advancement after Continuous Sinusoid Technology (CST). The uniqueness is that the wrapped in a Cobalt Alloy shell, the denser, more radiopaque inner core material allows for improved visibility during procedure, referred to as radiopacity.
"Core Wire Technology is an exciting innovation that will have measurable impact on clinical practice today and tomorrow," he said.
"When coronary stents fail to cross a tortuous anatomy they become ideal candidates for surgical revascularisation to provide relief from angina due to blocked artery. This is when Resolute Onyx DES comes into play due to its superior deliverability," the Hungarian Cardiologist said.
Hungary possesses the new solution for millions suffering from coronary artery diseases in India. Budapest-based Gottsegen Gyorgy Hungarian Institute of Cardiology has treated around 80 patients till now, with the new resolute onyx drug-eluting stent using the core wire technology. This new stent has thinner struts to help improve deliverability without compromising radial and longitudinal strength of the stent.
In addition, this new stent has no increased risk for stent thrombosis with interruption or discontinuation of dual antiplatelet therapy (DAPT) after a month. The Cobalt alloy shell of this new stent discovery is more flexible and, maintains the mechanical performance and structural strength of the stent material.
According to PTI,
"From a plain vanilla bare metal stent to the new generation Resolute Onyx drug eluting stents, it is a kind of revolution in stent technology," Chief of Adult Cardiology of Budapest-based Gottsegen Gyorgy Hungarian Institute of Cardiology Peter Andreka said.
Core Wire Technology is the next new DES advancement after Continuous Sinusoid Technology (CST). The uniqueness is that the wrapped in a Cobalt Alloy shell, the denser, more radiopaque inner core material allows for improved visibility during procedure, referred to as radiopacity.
"Core Wire Technology is an exciting innovation that will have measurable impact on clinical practice today and tomorrow," he said.
"When coronary stents fail to cross a tortuous anatomy they become ideal candidates for surgical revascularisation to provide relief from angina due to blocked artery. This is when Resolute Onyx DES comes into play due to its superior deliverability," the Hungarian Cardiologist said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.